Takeda Biopharmaceuticals India has received market authorization for its dengue vaccine QDENGA. This vaccine is now approved for individuals aged four to sixty years old. QDENGA offers protection ...
India Monday approved its first dengue vaccine, marking a significant milestone in the country’s fight against one of its ...
Dengue is a mosquito-borne viral disease reported in more than 125 countries. According to the company, India accounts for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results